Update: Influenza activity — United States, October 4–November 28, 2015

Morbidity and Mortality Weekly Report

Volumn 64, Issue 48, 2015, Pages 1342-1348

  Smith, Sophie ^a   Blanton, Lenee ^a   Kniss, Krista ^a   Mustaquim, Desiree ^a   Steffens, Craig ^a   Reed, Carrie ^a   Bramley, Anna ^a   Flannery, Brendan ^a   Fry, Alicia M ^a   Grohskopf, Lisa A ^a   Bresee, Joseph ^a   Wallis, Teresa ^a   Garten, Rebecca ^a   Xu, Xiyan ^a   Elal, Anwar Isa Abd ^a   Gubareva, Larisa ^a   Barnes, John ^a   Wentworth, David E ^a   Burns, Erin ^a   Katz, Jacqueline ^a   Jernigan, Daniel ^a   Brammer, Lynnette ^a   more..

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIVIRAL RESISTANCE; CHILD; CHILDHOOD MORTALITY; COMPLICATION; DRUG EFFECTS; HEALTH SURVEY; HUMAN; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; MORTALITY; NEWBORN; PNEUMONIA; PRESCHOOL CHILD; SEASON; STATISTICS AND NUMERICAL DATA; UNITED STATES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AMBULATORY CARE; ANTIVIRAL AGENTS; CHILD; CHILD MORTALITY; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA, HUMAN; MIDDLE AGED; PNEUMONIA; POPULATION SURVEILLANCE; SEASONS; UNITED STATES; YOUNG ADULT;

EID: 84951077932     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6448a4     Document Type: Article

References (8)

1. Schild GC, Oxford JS, de Jong JC, Webster RG. Evidence for host-cell selection of influenza virus antigenic variants. Nature 1983;303:706-9.
2. Katz JM, Wang M, Webster RG. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples reveals sequence identity with mammalian cell-grown virus. J Virol 1990;64:1808-11.
3. Flannery B, Clippard J, Zimmerman RK, et al. Early estimates of seasonal influenza vaccine effectiveness-United States, January 2015. MMWR Morb Mortal Wkly Rep 2015;64:10-5.
4. Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006;355:2513-22.
5. Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2015-16 influenza season. MMWR Morb Mortal Wkly Rep 2015;64:818-25.
6. CDC. Estimated influenza illnesses and hospitalizations averted by vaccination-United States, 2015-16 influenza season. Atlanta, GA: US Department of Health and Human Services, CDC. Available at http:// www.cdc.gov/flu/about/disease/2014-15.htm.
7. Neuzil KM, Jackson LA, Nelson J, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006;194:1032-9.
8. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60(No. RR-1).